Filing Details

Accession Number:
0001209191-13-036630
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-15 16:11:22
Reporting Period:
2013-07-11
Filing Date:
2013-07-15
Accepted Time:
2013-07-15 16:11:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406338 Amit Sachdev C/O Vertex Pharmaceuticals Incorporated
130 Waverly St.
Cambridge MA 02139
Svp, Global Gov. Strategy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-11 7,000 $33.28 35,987 No 4 M Direct
Common Stock Disposition 2013-07-11 7,000 $84.00 28,987 No 4 S Direct
Common Stock Acquisiton 2013-07-12 30,500 $33.55 59,487 No 4 M Direct
Common Stock Acquisiton 2013-07-12 7,000 $33.28 66,487 No 4 M Direct
Common Stock Disposition 2013-07-12 15,250 $85.00 51,237 No 4 S Direct
Common Stock Disposition 2013-07-12 7,000 $86.00 44,237 No 4 S Direct
Common Stock Disposition 2013-07-12 15,250 $87.00 28,987 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2013-07-11 7,000 $0.00 7,000 $33.28
Common Stock Stock Option Disposition 2013-07-12 7,000 $0.00 7,000 $33.28
Common Stock Stock Option Disposition 2013-07-12 30,500 $0.00 30,500 $33.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,500 2019-07-15 No 4 M Direct
16,500 2019-07-15 No 4 M Direct
30,500 2019-02-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 882 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
  2. The option vests in 16 quarterly installments from 07/16/2009.
  3. Fully vested.